Chenyu Wang – InmunoES

Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response

3 de June de 2026 by Chenyu Wang

BackgroundNeoadjuvant immunochemotherapy (NICT) is increasingly used in patients with locally advanced resectable esophageal squamous cell carcinoma (ESCC). However, optimal postoperative adjuvant treatment strategies remain unclear. This study aimed t…

Single-center experience with immune checkpoint inhibitor-related ureteritis and cystitis

20 de January de 2026 by Chenyu Wang

BackgroudUreteritis and cystitis is a rare immune-related adverse event (irAE) of immune checkpoint inhibitors (ICIs), challenging to distinguish from urinary tract infection (UTI), easily leading to missed diagnosis. We aim to describe clinical featur…